浙江医学
浙江醫學
절강의학
ZHEJIANG MEDICAL JOURNAL
2014年
3期
225-227
,共3页
右丙亚胺%CHOP方案%老年侵袭性非霍奇金淋巴瘤
右丙亞胺%CHOP方案%老年侵襲性非霍奇金淋巴瘤
우병아알%CHOP방안%노년침습성비곽기금림파류
Dexrazoxane CHOP regimen%Elderly patients with aggressive non- Hodgkin lymphoma
目的比较右丙亚胺联合CHOP方案与单用CHOP方案治疗老年侵袭性非霍奇金淋巴瘤(NHL)的临床疗效和不良反应。方法选取2010-2013年接受诊治的老年侵袭性NHL患者196例,随机分为治疗组和对照组,每组98例。治疗组患者给予右丙亚胺联合CHOP方案治疗,对照组给予CHOP方案治疗。比较两组患者的临床总有效率和不良反应的发生情况。结果治疗组临床总有效率为77.6%,对照组临床总有效率为76.5%,比较无统计学差异(P>0.05);两组患者心电图异常发生率、TnT- I和心电超声Tei指数均有所增加,且治疗3个疗程后增加最明显,但治疗组显著低于对照组(均P<0.05);两组患者的非心脏不良反应如血白细胞减少、血小板减少、恶心、呕吐等发生情况均差异不大(均P>0.05)。结论与单用CHOP方案比较,联合使用右丙亚胺和CHOP方案治疗老年侵袭性NHL的临床疗效显著,且可以显著降低其心脏毒性,值得临床推广应用。
目的比較右丙亞胺聯閤CHOP方案與單用CHOP方案治療老年侵襲性非霍奇金淋巴瘤(NHL)的臨床療效和不良反應。方法選取2010-2013年接受診治的老年侵襲性NHL患者196例,隨機分為治療組和對照組,每組98例。治療組患者給予右丙亞胺聯閤CHOP方案治療,對照組給予CHOP方案治療。比較兩組患者的臨床總有效率和不良反應的髮生情況。結果治療組臨床總有效率為77.6%,對照組臨床總有效率為76.5%,比較無統計學差異(P>0.05);兩組患者心電圖異常髮生率、TnT- I和心電超聲Tei指數均有所增加,且治療3箇療程後增加最明顯,但治療組顯著低于對照組(均P<0.05);兩組患者的非心髒不良反應如血白細胞減少、血小闆減少、噁心、嘔吐等髮生情況均差異不大(均P>0.05)。結論與單用CHOP方案比較,聯閤使用右丙亞胺和CHOP方案治療老年侵襲性NHL的臨床療效顯著,且可以顯著降低其心髒毒性,值得臨床推廣應用。
목적비교우병아알연합CHOP방안여단용CHOP방안치료노년침습성비곽기금림파류(NHL)적림상료효화불량반응。방법선취2010-2013년접수진치적노년침습성NHL환자196례,수궤분위치료조화대조조,매조98례。치료조환자급여우병아알연합CHOP방안치료,대조조급여CHOP방안치료。비교량조환자적림상총유효솔화불량반응적발생정황。결과치료조림상총유효솔위77.6%,대조조림상총유효솔위76.5%,비교무통계학차이(P>0.05);량조환자심전도이상발생솔、TnT- I화심전초성Tei지수균유소증가,차치료3개료정후증가최명현,단치료조현저저우대조조(균P<0.05);량조환자적비심장불량반응여혈백세포감소、혈소판감소、악심、구토등발생정황균차이불대(균P>0.05)。결론여단용CHOP방안비교,연합사용우병아알화CHOP방안치료노년침습성NHL적림상료효현저,차가이현저강저기심장독성,치득림상추엄응용。
Objective To investigate the efficacy and the adverse reactions of dexrazoxane combined with CHOP regi-men and CHOP regimen alone in treatment of elderly patients with aggressive non- Hodgkin lymphoma. Methods One hundred and ninety six elderly patients with aggressive non- Hodgkin lymphoma admitted in Shaoxing People's Hospital from January 2010 to January 2013 were randomly assigned to receive dexrazoxane combined with CHOP regimen or CHOP regimen alone with 98 cases in each group. The clinical efficacy rate and adverse reactions were compared between two groups. Results The clinical efficacy rates of combination and CHOP groups were 77.6%and 76.5%, respectively (P>0.05). The occurrence of elec-trocardiographic abnormality, the troponin I and the Tei index were increased and reached in the peak after 3 courses of treat-ment, however, the severity in combination group was milder than that in CHOP group(P<0.05). Conclusion CHOP regimen has satisfactory clinical efficacy in treatment of elderly patients with aggressive non- Hodgkin lymphoma, while combination of the regimen with dexrazoxane would reduce the cardiotoxicity of the treatment.